Automated description from the Alliance of Genome Resources (Release 3.1.1)
Predicted to have RNA binding activity; identical protein binding activity; and transcription termination site sequence-specific DNA binding activity. Involved in circadian rhythm and termination of RNA polymerase II transcription. Predicted to localize to several cellular components, including growth cone; intercellular bridge; and nuclear lumen. Human ortholog(s) of this gene implicated in amyotrophic lateral sclerosis type 4 and ataxia with oculomotor apraxia type 2. Orthologous to human SETX (senataxin).